Cargando…

Community differentiation of the cutaneous microbiota in psoriasis

BACKGROUND: Psoriasis is a common chronic inflammatory disease of the skin. We sought to characterize and compare the cutaneous microbiota of psoriatic lesions (lesion group), unaffected contralateral skin from psoriatic patients (unaffected group), and similar skin loci in matched healthy controls...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alekseyenko, Alexander V, Perez-Perez, Guillermo I, De Souza, Aieska, Strober, Bruce, Gao, Zhan, Bihan, Monika, Li, Kelvin, Methé, Barbara A, Blaser, Martin J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177411/ https://www.ncbi.nlm.nih.gov/pubmed/24451201 http://dx.doi.org/10.1186/2049-2618-1-31

Ejemplares similares

Microbiomic Signatures of Psoriasis: Feasibility and Methodology Comparison
por: Statnikov, Alexander, et al.
Publicado: (2013)

Effect of antibiotic pre-treatment and pathogen challenge on the intestinal microbiota in mice
por: Iizumi, Tadasu, et al.
Publicado: (2016)

Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic Lesions
por: Gao, Zhan, et al.
Publicado: (2008)

Analyses of the Stability and Core Taxonomic Memberships of the Human Microbiome
por: Li, Kelvin, et al.
Publicado: (2013)

Analyses of the Microbial Diversity across the Human Microbiome
por: Li, Kelvin, et al.
Publicado: (2012)

624. Microbiota and Associations with Treatment Outcome in Fecal Microbiota Transplantation
por: Bogdanovich, Tatiana, et al.
Publicado: (2018)

Combined biologic therapy for the treatment of psoriasis and psoriatic arthritis: A case report
por: Babalola, Olubukola, et al.
Publicado: (2014)

A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm
por: Strober, Bruce, et al.
Publicado: (2021)

Lower Extremity Cutaneous Lesions as the Initial Presentation of Metastatic Adenocarcinoma of the Colon
por: Rajan, Dhyan, et al.
Publicado: (2012)

Evidence for Differentiation of Colon Tissue Microbiota in Patients with and without Postoperative Hirschsprung's Associated Enterocolitis: A Pilot Study
por: Arbizu, Ricardo A., et al.
Publicado: (2021)

Atopy in cutaneous and arthropatic psoriasis
por: Hajdarbegovic, E, et al.
Publicado: (2010)

Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
por: Gottlieb, Alice B., et al.
Publicado: (2021)

Gut Microbiota in Psoriasis
por: Buhaș, Mihaela Cristina, et al.
Publicado: (2022)

The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles
por: Tarabichi, Y., et al.
Publicado: (2015)

Gut and oral microbiota associations with viral mitigation behaviors during the COVID-19 pandemic
por: Li, Kelvin, et al.
Publicado: (2022)

Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction
por: Yan, Bing-Xi, et al.
Publicado: (2021)

Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry
por: Strober, Bruce, et al.
Publicado: (2019)

Functional gene categories differentiate maize leaf drought-related microbial epiphytic communities
por: Methe, Barbara A., et al.
Publicado: (2020)

Patterns of clinical nail appearances in patients with cutaneous psoriasis
por: MARINA, ELENA MIHAELA, et al.
Publicado: (2017)

Psoriasis and Microbiota: A Systematic Review
por: Benhadou, Farida, et al.
Publicado: (2018)

Phylogenic inference using alignment-free methods for applications in microbial community surveys using 16s rRNA gene
por: Zhang, Yifei, et al.
Publicado: (2017)

Long‐term, durable, absolute Psoriasis Area and Severity Index and health‐related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate‐to‐severe plaque psoriasis
por: Gooderham, M., et al.
Publicado: (2022)

Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry
por: Lockshin, Benjamin, et al.
Publicado: (2021)

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council
por: Strober, Bruce, et al.
Publicado: (2019)

Editorial: Keep Calm and Care for Your Microbiota: The Role of H. pylori and Microbiota in Gastric Diseases
por: Grande, Rossella, et al.
Publicado: (2021)

MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis
por: Domingo, Sandra, et al.
Publicado: (2020)

Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting
por: Strober, Bruce, et al.
Publicado: (2022)

PERMANOVA-S: association test for microbial community composition that accommodates confounders and multiple distances
por: Tang, Zheng-Zheng, et al.
Publicado: (2016)

Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis
por: Woo, Yu Ri, et al.
Publicado: (2017)

Cutaneous Myiasis Caused by Chrysomya megacephala in an Infant with Psoriasis Vulgaris
por: Sangmala, Siripan, et al.
Publicado: (2020)

Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis
por: Popescu, Marius Nicolae, et al.
Publicado: (2022)

IL36G is associated with cutaneous antiviral competence in psoriasis
por: Lu, You-Wang, et al.
Publicado: (2022)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Involvement of Gut Microbiota in the Development of Psoriasis Vulgaris
por: Sun, Chaonan, et al.
Publicado: (2021)

Regulation of psoriasis, colitis, and the intestinal microbiota by clusterin
por: Jun, Yu Kyung, et al.
Publicado: (2023)

Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry
por: Mease, P.J., et al.
Publicado: (2019)

Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
por: Ghosh, Subrata, et al.
Publicado: (2019)

Child saliva microbiota and caries: a randomized controlled maternal education trial in rural Uganda
por: Muhoozi, Grace K. M., et al.
Publicado: (2022)

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
por: Ghosh, Subrata, et al.
Publicado: (2019)

Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization
por: Chang, Hsin-Wen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jlvl3idgip5p9ufbbrl2hbb8j1